The authors conducted a longitudinal evaluation of Sars-Cov-2 disease in the Kansas City and St. Louis regions of Missouri. The data was taken from the Missouri State Department of Health and Senior Services, evaluating the SARS-CoV-2 antigen or PCR tests performed in Missouri. They found that there is an increased burden of COVID-19 disease to black communities, but testing for COVID-19 did not increase to the same level. This finding remained constant over time, in all regions. Testing in black populations was always far from the goal necessary to optimize infection control. Although disparities narrowed in the later phases of the pandemic, this was due more to an increase in the case count among the white population than to an increase in testing in the black population. The authors suggest that testing equitably should be an immediate priority alongside work to decrease inequity in health care.